159 related articles for article (PubMed ID: 12476046)
21. Golgi GDP-fucose transporter-deficient mice mimic congenital disorder of glycosylation IIc/leukocyte adhesion deficiency II.
Hellbusch CC; Sperandio M; Frommhold D; Yakubenia S; Wild MK; Popovici D; Vestweber D; Gröne HJ; von Figura K; Lübke T; Körner C
J Biol Chem; 2007 Apr; 282(14):10762-72. PubMed ID: 17276979
[TBL] [Abstract][Full Text] [Related]
22. Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG) IIc founder effect and genotype/phenotype correlation.
Etzioni A; Sturla L; Antonellis A; Green ED; Gershoni-Baruch R; Berninsone PM; Hirschberg CB; Tonetti M
Am J Med Genet; 2002 Jun; 110(2):131-5. PubMed ID: 12116250
[TBL] [Abstract][Full Text] [Related]
23. Leukocyte adhesion deficiency II. Advances and open questions.
Yakubenia S; Wild MK
FEBS J; 2006 Oct; 273(19):4390-8. PubMed ID: 16956371
[TBL] [Abstract][Full Text] [Related]
24. Hematologically important mutations: Leukocyte adhesion deficiency (second update).
Roos D; van Leeuwen K; Madkaikar M; Kambli PM; Gupta M; Mathews V; Rawat A; Kuhns DB; Holland SM; de Boer M; Kanegane H; Parvaneh N; Lorenz M; Schwarz K; Klein C; Sherkat R; Jafari M; Wolach B; den Dunnen JT; Kuijpers TW; Köker MY
Blood Cells Mol Dis; 2023 Mar; 99():102726. PubMed ID: 36696755
[TBL] [Abstract][Full Text] [Related]
25. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency.
Lübke T; Marquardt T; Etzioni A; Hartmann E; von Figura K; Körner C
Nat Genet; 2001 May; 28(1):73-6. PubMed ID: 11326280
[TBL] [Abstract][Full Text] [Related]
26. Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands.
Bunting M; Harris ES; McIntyre TM; Prescott SM; Zimmerman GA
Curr Opin Hematol; 2002 Jan; 9(1):30-5. PubMed ID: 11753075
[TBL] [Abstract][Full Text] [Related]
27. Defining the mild variant of leukocyte adhesion deficiency type II (SLC35C1-congenital disorder of glycosylation) and response to l-fucose therapy: Insights from two new families and review of the literature.
Tahata S; Raymond K; Quade M; Barnes S; Boyer S; League S; Kumanovics A; Abraham R; Jacob E; Menon P; Morava E
Am J Med Genet A; 2022 Jul; 188(7):2005-2018. PubMed ID: 35338746
[TBL] [Abstract][Full Text] [Related]
28. Sweet solution: sugars to the rescue.
Freeze HH
J Cell Biol; 2002 Aug; 158(4):615-6. PubMed ID: 12186848
[TBL] [Abstract][Full Text] [Related]
29. Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus.
Smith PL; Myers JT; Rogers CE; Zhou L; Petryniak B; Becker DJ; Homeister JW; Lowe JB
J Cell Biol; 2002 Aug; 158(4):801-15. PubMed ID: 12186857
[TBL] [Abstract][Full Text] [Related]
30. Leukocyte adhesion deficiency type II: long-term follow-up and review of the literature.
Gazit Y; Mory A; Etzioni A; Frydman M; Scheuerman O; Gershoni-Baruch R; Garty BZ
J Clin Immunol; 2010 Mar; 30(2):308-13. PubMed ID: 20099014
[TBL] [Abstract][Full Text] [Related]
31. Incidental diagnosis of leukocyte adhesion deficiency type II following ABO typing.
Cooper N; Li YT; Möller A; Schulz-Weidner N; Sachs UJ; Wagner F; Hackstein H; Wienzek-Lischka S; Grüneberg M; Wild MK; Bein G; Marquardt T
Clin Immunol; 2020 Dec; 221():108599. PubMed ID: 32992000
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the SLC35C1 gene, contributing to significant differences in fucosylation patterns, may underlie the diverse phenotypic manifestations observed in leukocyte adhesion deficiency type II patients.
Skurska E; Szulc B; Kreczko K; Olczak M
Int J Biochem Cell Biol; 2024 Jun; 173():106602. PubMed ID: 38843991
[TBL] [Abstract][Full Text] [Related]
33. A new type of carbohydrate-deficient glycoprotein syndrome due to a decreased import of GDP-fucose into the golgi.
Lübke T; Marquardt T; von Figura K; Körner C
J Biol Chem; 1999 Sep; 274(37):25986-9. PubMed ID: 10473542
[TBL] [Abstract][Full Text] [Related]
34. Leukocyte adhesion deficiencies.
Hanna S; Etzioni A
Ann N Y Acad Sci; 2012 Feb; 1250():50-5. PubMed ID: 22276660
[TBL] [Abstract][Full Text] [Related]
35. Decreased availability of GDP-L-fucose in a patient with LAD II with normal GDP-D-mannose dehydratase and FX protein activities.
Körner C; Linnebank M; Koch HG; Harms E; von Figura K; Marquardt T
J Leukoc Biol; 1999 Jul; 66(1):95-8. PubMed ID: 10410995
[TBL] [Abstract][Full Text] [Related]
36. Leukocyte trafficking in a mouse model for leukocyte adhesion deficiency II/congenital disorder of glycosylation IIc.
Yakubenia S; Frommhold D; Schölch D; Hellbusch CC; Körner C; Petri B; Jones C; Ipe U; Bixel MG; Krempien R; Sperandio M; Wild MK
Blood; 2008 Aug; 112(4):1472-81. PubMed ID: 18541720
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2.
Phillips ML; Schwartz BR; Etzioni A; Bayer R; Ochs HD; Paulson JC; Harlan JM
J Clin Invest; 1995 Dec; 96(6):2898-906. PubMed ID: 8675661
[TBL] [Abstract][Full Text] [Related]
38. Adhesion molecule deficiencies and their clinical significance.
Etzioni A
Cell Adhes Commun; 1994 Jul; 2(3):257-60. PubMed ID: 7827963
[TBL] [Abstract][Full Text] [Related]
39. Genetic etiologies of leukocyte adhesion defects.
Etzioni A
Curr Opin Immunol; 2009 Oct; 21(5):481-6. PubMed ID: 19647987
[TBL] [Abstract][Full Text] [Related]
40. Molecular physiology and pathology of the nucleotide sugar transporter family (SLC35).
Ishida N; Kawakita M
Pflugers Arch; 2004 Feb; 447(5):768-75. PubMed ID: 12759756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]